Davion Healthcare Plc Ordinary Shares（DAVI）股票分析

AI 分析 of Davion Healthcare Plc Ordinary Shares (DAVI)

賣出

Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.

估值指標

Davion Healthcare Plc Ordinary Shares（DAVI）目前預期本益比為 0.00，5 年平均預期本益比為。

預期本益比

5 年均值 P/E

目前P/E

0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA

目前EV/EBITDA

0.00

預期股價營收比

5 年均值 P/S

目前P/S

0.00

DAVI 常見問題 —— 由 Alphio AI 解答

Daviion Healthcare Plc is not a good buy right now due to its significant decline in value and lack of positive financial indicators. The stock has dropped 89.17% year-to-date and is currently trading at $1.49, which is very close to its 52-week low of $1.46. Additionally, the company has a price-to-book ratio of 31.6019, indicating it is highly overvalued compared to its assets. The recent acquisitions may provide some future potential, but the current performance and high risk outweigh these factors.

Davion Healthcare Plc Ordinary Shares（DAVI）股票分析

AI 分析 of Davion Healthcare Plc Ordinary Shares (DAVI)

估值指標

預期本益比

預期 EV/EBITDA

預期股價營收比

資訊

DAVI 常見問題 —— 由 Alphio AI 解答

社群

相關文章